Clinical Trial Update: Eltrombopag in Chronic ITP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for eltrombopag in chronic immune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Assiut University | Conditions: Immune Thrombocytopenia | Phase 4 | Status: UNKNOWN